Matthias Eiber

14.9k total citations · 10 hit papers
189 papers, 10.8k citations indexed

About

Matthias Eiber is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Matthias Eiber has authored 189 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Pulmonary and Respiratory Medicine, 123 papers in Radiology, Nuclear Medicine and Imaging and 29 papers in Oncology. Recurrent topics in Matthias Eiber's work include Prostate Cancer Treatment and Research (155 papers), Radiopharmaceutical Chemistry and Applications (101 papers) and Prostate Cancer Diagnosis and Treatment (95 papers). Matthias Eiber is often cited by papers focused on Prostate Cancer Treatment and Research (155 papers), Radiopharmaceutical Chemistry and Applications (101 papers) and Prostate Cancer Diagnosis and Treatment (95 papers). Matthias Eiber collaborates with scholars based in Germany, United States and Switzerland. Matthias Eiber's co-authors include Tobias Maurer, Markus Schwaiger, Jürgen E. Gschwend, Hans‐Jürgen Wester, Isabel Rauscher, Ambros J. Beer, Michael Souvatzoglou, Bernhard Haller, Matthias Heck and Gregor Weirich and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Matthias Eiber

183 papers receiving 10.7k citations

Hit Papers

Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patie... 2015 2026 2018 2022 2015 2015 2017 2016 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
    2015 813 citations Matthias Eiber, Tobias Maurer et al. Journal of Nuclear Medicine profile →
  2. Diagnostic Efficacy of 68 Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
    2015 595 citations Tobias Maurer, Jürgen E. Gschwend et al. profile →
  3. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
    2017 567 citations Wolfgang P. Fendler, Matthias Eiber et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
  4. Current use of PSMA–PET in prostate cancer management
    2016 461 citations Tobias Maurer, Matthias Eiber et al. Nature Reviews Urology profile →
  5. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
    2015 419 citations Matthias Eiber, Markus Schwaiger et al. Journal of Nuclear Medicine profile →
  6. Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
    2016 418 citations Matthias Eiber, Konstantin Holzapfel et al. profile →
  7. Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer
    2016 280 citations Robert Tauber, Matthias Heck et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
  8. Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls
    2018 266 citations Tobias Maurer, Matthias Eiber et al. profile →
  9. Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
    2018 248 citations Karina Knorr, Tobias Maurer et al. Journal of Nuclear Medicine profile →
  10. E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
    2021 214 citations Johannes Czernin, Matthias Eiber et al. European Journal of Nuclear Medicine and Molecular Imaging profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Eiber Germany 53 8.9k 6.8k 2.1k 1.3k 1.0k 189 10.8k
Ali Afshar‐Oromieh Germany 45 6.9k 0.8× 6.9k 1.0× 2.0k 1.0× 606 0.5× 747 0.7× 149 9.2k
Wolfgang P. Fendler Germany 47 5.7k 0.6× 5.1k 0.7× 2.2k 1.1× 598 0.5× 1.1k 1.1× 294 8.3k
Michael S. Hofman Australia 54 7.1k 0.8× 6.5k 0.9× 3.0k 1.5× 724 0.6× 1.2k 1.2× 325 11.6k
Maria Picchio Italy 46 4.4k 0.5× 4.0k 0.6× 890 0.4× 615 0.5× 991 1.0× 202 7.5k
Janet F. Eary United States 58 3.6k 0.4× 5.2k 0.8× 2.7k 1.3× 900 0.7× 1.3k 1.3× 175 10.0k
Matthias Eiber Germany 42 4.1k 0.5× 4.5k 0.7× 1.1k 0.6× 405 0.3× 626 0.6× 200 6.2k
Thomas A. Hope United States 50 4.5k 0.5× 4.6k 0.7× 1.8k 0.9× 395 0.3× 583 0.6× 272 8.8k
Hebert Alberto Vargas United States 49 4.2k 0.5× 3.6k 0.5× 1.1k 0.6× 852 0.7× 756 0.7× 211 7.8k
Piet Ost Belgium 44 5.9k 0.7× 2.2k 0.3× 1.7k 0.8× 688 0.5× 1.1k 1.1× 249 7.9k
Louise Emmett Australia 40 4.2k 0.5× 2.9k 0.4× 1.1k 0.5× 629 0.5× 564 0.6× 188 5.5k

Countries citing papers authored by Matthias Eiber

Since Specialization
Citations

This map shows the geographic impact of Matthias Eiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Eiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Eiber more than expected).

Fields of papers citing papers by Matthias Eiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Eiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Eiber. The network helps show where Matthias Eiber may publish in the future.

Co-authorship network of co-authors of Matthias Eiber

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Eiber. A scholar is included among the top collaborators of Matthias Eiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Eiber. Matthias Eiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Unterrainer, Lena M., et al.. (2025). The role of non-FDG agents in PET imaging of bladder cancer. Seminars in Nuclear Medicine. 56(2). 188–199.
2.
Rauscher, Isabel, Song Xue, Andrei Gafita, et al.. (2025). Characterization of Effective Half-Life for Instant Single-Time-Point Dosimetry Using Machine Learning. Journal of Nuclear Medicine. 66(5). 778–784. 3 indexed citations
3.
Heck, Matthias, Robert Tauber, Calogero D’Alessandria, et al.. (2024). Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval. EJNMMI Research. 14(1). 94–94. 2 indexed citations
4.
Mayr, Roman, Maximilian Haas, Marco J. Schnabel, et al.. (2024). Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients. World Journal of Urology. 42(1). 483–483. 1 indexed citations
5.
Knipper, Sophie, Matthias Eiber, Fijs W. B. van Leeuwen, et al.. (2024). Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen–targeted Salvage Surgery. European Urology Oncology. 8(2). 270–277. 9 indexed citations
6.
Mansi, Rosalba, Luigi Del Pozzo, Raghuvir H. Gaonkar, et al.. (2024). 61Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging. Journal of Nuclear Medicine. 65(9). 1427–1434. 8 indexed citations
7.
Falkenbach, Fabian, Francesca Ambrosini, Pierre Tennstedt, et al.. (2023). EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer. Cancers. 15(20). 5008–5008. 5 indexed citations
8.
Feuerecker, Benedikt, Karina Knorr, Matthias Heck, et al.. (2023). Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of177Lu-PSMA I&T. Journal of Nuclear Medicine. 64(11). 1765–1771. 4 indexed citations
9.
Harder, F, Friederike Jungmann, Georgios Kaissis, et al.. (2021). [18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma. EJNMMI Research. 11(1). 70–70. 15 indexed citations
10.
Vogel, Marco M. E., Stephanie Kroeze, Christoph Henkenberens, et al.. (2020). Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy. European Journal of Nuclear Medicine and Molecular Imaging. 47(10). 2328–2338. 12 indexed citations
11.
Kessler, Lukas, Anna Melissa Schlitter, Martin Krönke, et al.. (2020). First Experience Using 18F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or Paraganglioma. Journal of Nuclear Medicine. 62(4). 479–485. 5 indexed citations
12.
Zamboglou, Constantinos, Matthias Eiber, Matthias Eder, et al.. (2018). Multimodal imaging for radiation therapy planning in patients with primary prostate cancer. Physics and Imaging in Radiation Oncology. 8. 8–16. 6 indexed citations
13.
Maurer, Tobias & Matthias Eiber. (2018). Practice changing for prostate cancer: a vision of the future. Nature Reviews Urology. 16(2). 71–72. 5 indexed citations
14.
Pfob, Christian H., Matthias Eiber, Peter B. Luppa, et al.. (2018). Hyperkalemia in patients treated with endoradiotherapy combined with amino acid infusion is associated with severe metabolic acidosis. EJNMMI Research. 8(1). 17–17. 4 indexed citations
15.
Barrio, Martin, Johannes Czernin, Stefano Fanti, et al.. (2017). The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis. Journal of Nuclear Medicine. 58(5). 756–761. 133 indexed citations
16.
Habl, Gregor, et al.. (2017). 68 Ga-PSMA-PET for Radiation Treatment Planning in Prostate Cancer Recurrences After Surgery: Individualized Medicine or New Standard in Salvage Treatment. International Journal of Radiation Oncology*Biology*Physics. 99(2). S98–S99. 5 indexed citations
17.
Düwel, Charlotte, et al.. (2016). Rektummukosametastase beim Prostatakarzinomrezidiv. Der Urologe. 55(8). 1086–1088. 1 indexed citations
18.
Maurer, Tobias, Thomas Horn, Ambros J. Beer, Matthias Eiber, & Jürgen E. Gschwend. (2013). Funktionelle Bildgebung beim Harnblasenkarzinom. Der Urologe. 52(4). 509–514. 1 indexed citations
19.
20.
Holzapfel, Konstantin, Carolin Reiser–Erkan, Alexander A. Fingerle, et al.. (2010). Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer. Abdominal Imaging. 36(2). 179–184. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali Afshar‐Oromieh Breakdown of academic impact, for papers by Wolfgang P. Fendler Breakdown of academic impact, for papers by Michael S. Hofman Breakdown of academic impact, for papers by Maria Picchio Breakdown of academic impact, for papers by Janet F. Eary Breakdown of academic impact, for papers by Matthias Eiber Breakdown of academic impact, for papers by Thomas A. Hope Breakdown of academic impact, for papers by Hebert Alberto Vargas Breakdown of academic impact, for papers by Piet Ost Breakdown of academic impact, for papers by Louise Emmett
Rankless by CCL
2026